EMU-116
EMU-116 is an orally active CXCR4 antagonist. EMU-116 can be used in the study of cancer[1].
Product Specifications
CAS Number
2241724-59-2
UNSPSC
12352005
Target
CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/emu-116.html
Purity
98.53
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN1CCN(C2=CC=CC3=C2C[C@H](CN(C)[C@H]4CCCC5=C4N=CC=C5)NC3)CC1
Molecular Formula
C25H35N5
Molecular Weight
405.58
References & Citations
[1]Jacobs L, et al. Scale-Up Preparation of Best-In-Class Orally Bioavailable CXCR4 Antagonist EMU-116 in an Academic Setting[J]. Organic Process Research & Development, 2024.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY402344 100 µg
Rabex5 (RABGEF1) (NM_014504) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-B285920-50MG 50 mg
(S)-3-Benzyloxycarbonyl-4-(3-oxobutyl)-5-oxazilidinone
Sign In for Pricing
View Details